Rio Mpox Cases Exceed 2025 Total, says State Health Secretariat
The state of Rio de Janeiro registered 211 confirmed cases of Mpox by November 1, 2026, surpassing the total of 119 cases recorded throughout all of 2025, according to the Rio de Janeiro State Health Secretariat.
-
Key Clinical Takeaways:
- Rio de Janeiro recorded 211 confirmed Mpox cases by November 1, 2026, exceeding the 119 cases from 2025.
- Federal health authorities reinforced vaccine shipments to Rio de Janeiro to control the current spread, focusing on specific high-risk groups.
- Experts and officials emphasize that the 2026 caseload remains far below the widespread transmission levels seen during the 2022 outbreak.
Statewide Caseload Surpasses Previous Year Totals
Data from the Centro de Informações Estratégicas e Resposta de Vigilância em Saúde show that the 211 infections confirmed in the state surpass the prior year’s total without any reported deaths during these periods, reported. Within the capital city, the municipal epidemiological panel updated through October 29 recorded 167 confirmed cases, compared to 94 during the entirety of the previous year. O Globo noted that the growth in registrations is driven largely by September and October, which accounted for 90 diagnoses, representing an increase compared to the same period in 2025. An additional 117 cases remain under active investigation across the state.
Federal Government Sends More Vaccines to Rio De Janeiro
Federal health minister Alexandre Padilha announced on social media on October 31 that the federal government has reinforced the volume of vaccines sent to Rio de Janeiro to control current infections and prepare for end-of-year gatherings, according to Poder360. Padilha stated that the Ministry of Health maintains active surveillance alongside state and municipal agencies, asserting that the SUS is prepared to diagnose, treat, and monitor patients. He emphasized that the current national total of 665 cases in 2026 differs significantly from the 2022 outbreak, when infections reached nearly 11,000.
É importante esclarecer que a situação atual, com 665 casos da doença no Brasil no ano, é bem diferente do surto enfrentado em 2022, quando chegamos a quase 11 mil pessoas infectadas, 1.527% a mais
Soranz also pointed out that vaccine availability remains limited relative to the population at risk.
MPXV Virus Causes Skin Lesions and Fever
Mpox is an infectious viral disease caused by the MPXV virus, formerly referred to as monkeypox, a nomenclature updated by the World Health Organization at the end of 2022 to reduce social stigma and standardize terminology. Classic symptoms include fever, body aches, exhaustion, and swollen lymph nodes, followed by skin lesions appearing three to four days later. Transmission occurs through direct contact with skin lesions, bodily fluids, respiratory secretions during close or prolonged face-to-face interactions, and contaminated personal items such as bedding and towels. While most patients experience spontaneous recovery, severe illness is primarily associated with compromised immune systems.
Health Secretariat Recommends Avoiding Contact with Suspected Cases
The State Health Secretariat recommends avoiding physical contact with individuals displaying suspicious skin or mucosal lesions, refraining from intimate contact or sexual relations until evaluated by a healthcare professional, and avoiding the sharing of personal items. Patients with suspected symptoms—especially in genital, anal, or oral regions—are advised to seek medical evaluation and follow isolation guidelines until rashes are completely healed. Vaccination via the Sistema Único de Saúde remains restricted to specific groups defined by the Ministry of Health, including laboratory professionals working directly with the virus, severely immunosuppressed individuals living with HIV, and those who experienced direct medium- or high-risk contact with confirmed or suspected cases. Patients seeking specialized evaluation in Rio de Janeiro can access care services at the Instituto Nacional de Infectologia Evandro Chagas, located at Fiocruz in Manguinhos, or at the Núcleo de Enfrentamento e Estudos de Doenças Infecciosas Emergentes e Reemergentes at the Universidade Federal do Rio de Janeiro.
Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.
